NCT02485600

Observational Study Evaluating Long-term Health Outcomes of Canadian Patients on an Active Drug-treatment

Brief summary

This is an open-label, postmarketing, observational study to document health outcomes, in Canadian patients with advanced Parkinson's disease and long-term treatment with an active drug (active drug intestinal gel).

Observational study

Status:
Completed
Conditions:
Parkinson Disease (PD)
Enrollment:
88 patients
Protocol ID:
P14-506
Observational model:
Cohort
Time perspective:
Prospective

Would you like to know more about this trial?

Yes, please contact me

Eligibility criteria

Participant attributes:
Male and Female

Age:

From 18 Years to 99 Years.

Inclusion Criteria:

- Diagnosed with advanced Parkinson's Disease

- Prescribed Duodopa by his/her treating physician.

Exclusion Criteria:

- Patients who were previously treated with Duodopa.

- Presence of other condition that, in the opinion of the treating physician, prohibits
the patient from participating in the study or obscures the assessment of the
treatment of advanced PD.

All the cities where the clinical studies are located